|
⚲
|
| Keyboard |
| Johnson Brady
✚
|
|
|---|---|
| CIK # | 0001751478 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001751478] | |
| 4 | [0001751478] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| K2 Therapeutics Inc | |
| Johnson Brady |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-31 | Grant | 10,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Employee Stock Option (right to buy) · derivative
|
2022-03-31 | Grant | 20,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-21 | Sell | 654 | $0.81 | 530 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-03-11 | Sell | 945 | $0.71 | 671 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2022-01-05 | Sell | 416 | $1.25 | 520 |
|
K2 Therapeutics Inc CDTX
Restricted Stock Unit · derivative
|
2021-12-29 | Option exercise | 262 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2021-12-29 | Option exercise | 262 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2021-09-30 | Grant | 20,750 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2021-07-30 | Grant | 20,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (Right to Buy) · derivative
|
2018-09-14 | Grant | 4,000 | $0.00 |